Efficacité et tolérance du tocilizumab en pratique quotidienne chez 26 patients atteints de polyarthrite rhumatoïde

G. Cinquetti(Hôpital d'instruction des Armées Desgenettes), Jacques‐Eric Gottenberg(Hôpitaux Universitaires de Strasbourg), Christelle Sordet, Rose‐Marie Javier(Laboratoire National de Référence), Jean Sibilia(Immunologie, Immunopathologie et Chimie Thérapeutique), Emmanuel Chatelus(Laboratoire National de Référence), Hélène Chifflot(Hôpital d'Hautepierre)
La Revue de Médecine Interne
November 25, 2010
10.1016/j.revmed.2010.10.016
Cited by 0

Related Papers

<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Incidence and Prevalence of Systemic Sclerosis: A Systematic Literature Review
|Seminars in Arthritis and Rheumatism|2007|456
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432
Lymphomas in Patients With Sjogren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
|Blood|1997|346
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207